T2 Biosystems, Inc. Variable Lease, Cost
T2 Biosystems, Inc. reported Variable Lease, Cost of $957.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2024-04-01
- T2 Biosystems, Inc. variable lease, cost for the quarter ending 2019-12-31 was $176.00K.
- T2 Biosystems, Inc. variable lease, cost for the quarter ending 2019-09-30 was $163.00K.
- T2 Biosystems, Inc. variable lease, cost for the quarter ending 2019-06-30 was $148.00K.
- T2 Biosystems, Inc. variable lease, cost for the quarter ending 2019-03-31 was $172.00K.
- T2 Biosystems, Inc. variable lease, cost for fiscal 2023 was $957.00K, a 4.59% increase from fiscal 2022.
- T2 Biosystems, Inc. variable lease, cost for fiscal 2022 was $915.00K, a 31.09% increase from fiscal 2021.
- T2 Biosystems, Inc. variable lease, cost for fiscal 2021 was $698.00K, a 7.43% decline from fiscal 2020.
- T2 Biosystems, Inc. variable lease, cost for fiscal 2020 was $754.00K, a 14.42% increase from fiscal 2019.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $957.00K 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $915.00K 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $698.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $754.00K 10-K · filed 2022-03-23 | |||
| 2019-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $339.00K derived: sum of 2 quarters · filed 2021-03-31 | $487.00K derived: sum of 3 quarters · filed 2021-03-31 | $659.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $163.00K 10-Q · filed 2019-11-18 | $311.00K derived: sum of 2 quarters · filed 2019-11-18 | $483.00K 10-Q · filed 2019-11-18 | |
| 2019-06-30 | $148.00K 10-Q · filed 2019-08-02 | $320.00K 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $172.00K 10-Q · filed 2019-05-10 |